Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)
- PMID: 22422217
- DOI: 10.1039/c2lc40094d
Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB)
Abstract
The blood-brain barrier (BBB), a unique selective barrier for the central nervous system (CNS), hinders the passage of most compounds to the CNS, complicating drug development. Innovative in vitro models of the BBB can provide useful insights into its role in CNS disease progression and drug delivery. Static transwell models lack fluidic shear stress, while the conventional dynamic in vitro BBB lacks a thin dual cell layer interface. To address both limitations, we developed a microfluidic blood-brain barrier (μBBB) which closely mimics the in vivo BBB with a dynamic environment and a comparatively thin culture membrane (10 μm). To test validity of the fabricated BBB model, μBBBs were cultured with b.End3 endothelial cells, both with and without co-cultured C8-D1A astrocytes, and their key properties were tested with optical imaging, trans-endothelial electrical resistance (TEER), and permeability assays. The resultant imaging of ZO-1 revealed clearly expressed tight junctions in b.End3 cells, Live/Dead assays indicated high cell viability, and astrocytic morphology of C8-D1A cells were confirmed by ESEM and GFAP immunostains. By day 3 of endothelial culture, TEER levels typically exceeded 250 Ω cm(2) in μBBB co-cultures, and 25 Ω cm(2) for transwell co-cultures. Instantaneous transient drop in TEER in response to histamine exposure was observed in real-time, followed by recovery, implying stability of the fabricated μBBB model. Resultant permeability coefficients were comparable to previous BBB models, and were significantly increased at higher pH (>10). These results demonstrate that the developed μBBB system is a valid model for some studies of BBB function and drug delivery.
Similar articles
-
A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.Neurochem Int. 2009 Mar-Apr;54(3-4):253-63. doi: 10.1016/j.neuint.2008.12.002. Epub 2008 Dec 7. Neurochem Int. 2009. PMID: 19111869
-
BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function.Biomed Microdevices. 2013 Feb;15(1):145-50. doi: 10.1007/s10544-012-9699-7. Biomed Microdevices. 2013. PMID: 22955726
-
Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.Biotechnol Bioeng. 2017 Jan;114(1):184-194. doi: 10.1002/bit.26045. Epub 2016 Jul 21. Biotechnol Bioeng. 2017. PMID: 27399645 Free PMC article.
-
Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.Expert Opin Drug Discov. 2015 Feb;10(2):141-55. doi: 10.1517/17460441.2015.974545. Epub 2014 Nov 12. Expert Opin Drug Discov. 2015. PMID: 25388782 Review.
-
Adenosine receptor signaling: a key to opening the blood-brain door.Fluids Barriers CNS. 2015 Sep 2;12:20. doi: 10.1186/s12987-015-0017-7. Fluids Barriers CNS. 2015. PMID: 26330053 Free PMC article. Review.
Cited by
-
Advances and Challenges of Bioassembly Strategies in Neurovascular In Vitro Modeling: An Overview of Current Technologies with a Focus on Three-Dimensional Bioprinting.Int J Mol Sci. 2024 Oct 12;25(20):11000. doi: 10.3390/ijms252011000. Int J Mol Sci. 2024. PMID: 39456783 Free PMC article. Review.
-
Composite Hydrogels in Three-Dimensional in vitro Models.Front Bioeng Biotechnol. 2020 Jun 16;8:611. doi: 10.3389/fbioe.2020.00611. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32656197 Free PMC article. Review.
-
Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs-Protocols and Advice for the FDA to Meet the ALS Act Vision.Int J Mol Sci. 2024 Sep 23;25(18):10211. doi: 10.3390/ijms251810211. Int J Mol Sci. 2024. PMID: 39337696 Free PMC article. Review.
-
Transferrin Aptamers Increase the In Vivo Blood-Brain Barrier Targeting of Protein Spherical Nucleic Acids.Bioconjug Chem. 2022 Oct 19;33(10):1803-1810. doi: 10.1021/acs.bioconjchem.2c00389. Epub 2022 Oct 4. Bioconjug Chem. 2022. PMID: 36194889 Free PMC article.
-
Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development.Bioengineering (Basel). 2022 Apr 2;9(4):150. doi: 10.3390/bioengineering9040150. Bioengineering (Basel). 2022. PMID: 35447710 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous